These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 25202944)

  • 1. [Preparation and evaluation of RGD and TAT co-modified paclitaxel loaded liposome].
    Gao B; Mu W
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2014 Aug; 39(8):769-74. PubMed ID: 25202944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Preparation of cell penetrating peptide TAT and cleavable PEGco-modified liposomes loaded with paclitaxel and its in vitro apoptosis assay].
    Fu H; Hu GL; He Q
    Yao Xue Xue Bao; 2014 Jul; 49(7):1054-61. PubMed ID: 25233640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of dual-functional liposomes containing paclitaxel for treatment of lung cancer.
    Wang RH; Cao HM; Tian ZJ; Jin B; Wang Q; Ma H; Wu J
    Oncol Rep; 2015 Feb; 33(2):783-91. PubMed ID: 25482610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of integrin receptor-targeted liposomal paclitaxel for hepatocellular carcinoma targeting and therapy.
    Chen L; Liu Y; Wang W; Liu K
    Oncol Lett; 2015 Jul; 10(1):77-84. PubMed ID: 26170980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation and evaluation of RGD and TAT co-modified docetaxel-loaded liposome.
    Zhu R; Tian Y
    Drug Des Devel Ther; 2017; 11():3481-3489. PubMed ID: 29255349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-tumor effect of RGD modified PTX loaded liposome on prostatic cancer.
    Cao Y; Zhou Y; Zhuang Q; Cui L; Xu X; Xu R; He X
    Int J Clin Exp Med; 2015; 8(8):12182-91. PubMed ID: 26550128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor-targeted paclitaxel delivery and enhanced penetration using TAT-decorated liposomes comprising redox-responsive poly(ethylene glycol).
    Fu H; Shi K; Hu G; Yang Y; Kuang Q; Lu L; Zhang L; Chen W; Dong M; Chen Y; He Q
    J Pharm Sci; 2015 Mar; 104(3):1160-73. PubMed ID: 25449709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted Nanostructured Lipid Carriers for Delivery of Paclitaxel to Cancer Cells: Preparation, Characterization, and Cell Toxicity.
    Rezazadeh M; Emami J; Hassanzadeh F; Sadeghi H; Rostami M; Mohammadkhani H
    Curr Drug Deliv; 2017; 14(8):1189-1200. PubMed ID: 28472908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased tumor targeted delivery using a multistage liposome system functionalized with RGD, TAT and cleavable PEG.
    Mei L; Fu L; Shi K; Zhang Q; Liu Y; Tang J; Gao H; Zhang Z; He Q
    Int J Pharm; 2014 Jul; 468(1-2):26-38. PubMed ID: 24709209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RGD-based strategies for improving antitumor activity of paclitaxel-loaded liposomes in nude mice xenografted with human ovarian cancer.
    Zhao H; Wang JC; Sun QS; Luo CL; Zhang Q
    J Drug Target; 2009 Jan; 17(1):10-8. PubMed ID: 19016068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dual-functionalized liposomal delivery system for solid tumors based on RGD and a pH-responsive antimicrobial peptide.
    Zhang Q; Lu L; Zhang L; Shi K; Cun X; Yang Y; Liu Y; Gao H; He Q
    Sci Rep; 2016 Feb; 6():19800. PubMed ID: 26842655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arginine, glycine, aspartic acid peptide-modified paclitaxel and curcumin co-loaded liposome for the treatment of lung cancer: in vitro/vivo evaluation.
    Jiang K; Shen M; Xu W
    Int J Nanomedicine; 2018; 13():2561-2569. PubMed ID: 29731631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrin αvβ3 and LHRH Receptor Double Directed Nano-Analogue Effective Against Ovarian Cancer in Mice Model.
    Qi N; Zhou X; Ma N; Zhang J; Wang Z; Zhang X; Li A
    Int J Nanomedicine; 2024; 19():3071-3086. PubMed ID: 38562611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dual-active targeting liposomes drug delivery system for bone metastatic breast cancer: Synthesis and biological evaluation.
    Zhao Z; Zhao Y; Xie C; Chen C; Lin D; Wang S; Lin D; Cui X; Guo Z; Zhou J
    Chem Phys Lipids; 2019 Sep; 223():104785. PubMed ID: 31194968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced anticancer efficacy of paclitaxel through multistage tumor-targeting liposomes modified with RGD and KLA peptides.
    Sun J; Jiang L; Lin Y; Gerhard EM; Jiang X; Li L; Yang J; Gu Z
    Int J Nanomedicine; 2017; 12():1517-1537. PubMed ID: 28280323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Physicochemical Property of iRGD Peptide Modified Doxorubicin Loaded Liposome and Its Effect on Cancer Cell Growth].
    Zhang ZQ; Zhong CL; Zhao X
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2015 Nov; 46(6):837-41. PubMed ID: 26867317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RGD conjugated liposome-hollow silica hybrid nanovehicles for targeted and controlled delivery of arsenic trioxide against hepatic carcinoma.
    Fei W; Zhang Y; Han S; Tao J; Zheng H; Wei Y; Zhu J; Li F; Wang X
    Int J Pharm; 2017 Mar; 519(1-2):250-262. PubMed ID: 28109899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RGD-modified pH-sensitive liposomes for docetaxel tumor targeting.
    Chang M; Lu S; Zhang F; Zuo T; Guan Y; Wei T; Shao W; Lin G
    Colloids Surf B Biointerfaces; 2015 May; 129():175-82. PubMed ID: 25851582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vitamin E Succinate-Grafted-Chitosan Oligosaccharide/RGD-Conjugated TPGS Mixed Micelles Loaded with Paclitaxel for U87MG Tumor Therapy.
    Chen Y; Feng S; Liu W; Yuan Z; Yin P; Gao F
    Mol Pharm; 2017 Apr; 14(4):1190-1203. PubMed ID: 28212490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antitumor effect of iRGD-modified liposomes containing conjugated linoleic acid-paclitaxel (CLA-PTX) on B16-F10 melanoma.
    Du R; Zhong T; Zhang WQ; Song P; Song WD; Zhao Y; Wang C; Tang YQ; Zhang X; Zhang Q
    Int J Nanomedicine; 2014; 9():3091-105. PubMed ID: 25028548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.